Fig. 1
From: Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test
CAB risk stratification in male and female patients. Graph representing the comparison of CAB low-risk and high-risk proportions in female and male patients. Chi squared test was used to calculate P values on MedCalc software.
